share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leschly Nick

SEC ·  Nov 9 05:17

Summary by Futu AI

On November 6, 2024, Nick Leschly, associated with bluebird bio, Inc. [BLUE], completed a transaction involving the direct acquisition of 24,900 shares of common stock at no cost. Following this transaction, Leschly's direct holdings in the company increased to a total of 315,839 shares. Additionally, Leschly holds an indirect interest in 168,699 shares through entities such as the Nick Leschly 2001 Trust and the Nick Leschly Irrevocable GST Trust of 2019. The nature of the transaction was classified as a grant, which typically indicates an award or acquisition related to compensation or incentive programs.
On November 6, 2024, Nick Leschly, associated with bluebird bio, Inc. [BLUE], completed a transaction involving the direct acquisition of 24,900 shares of common stock at no cost. Following this transaction, Leschly's direct holdings in the company increased to a total of 315,839 shares. Additionally, Leschly holds an indirect interest in 168,699 shares through entities such as the Nick Leschly 2001 Trust and the Nick Leschly Irrevocable GST Trust of 2019. The nature of the transaction was classified as a grant, which typically indicates an award or acquisition related to compensation or incentive programs.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.